Fatty acid synthase regulates the chemosensitivity of breast cancer cells to cisplatin-induced apoptosis

Shadia Al-Bahlani, Hanaa Al-Lawati, Moza Al-Adawi, Nadia Al-Abri, Buthaina Al-Dhahli, Kawther Al-Adawi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Fatty acid synthase (FASN) is a key enzyme in fat biosynthesis that is over-expressed in advanced breast cancer stages. Cisplatin (CDDP) is a platinum-based drug used in the treatment of certain types of this disease. Although it was shown that FASN inhibition induced apoptosis by enhancing the cytotoxicity of certain drugs in breast cancer, its role in regulating the chemosensitivity of different types of breast cancer cells to CDDP-induced apoptosis is not established yet. Therefore, two different breast cancer cell lines; triple negative breast cancer (TNBC; MDA-MB-231) and triple positive breast cancer (TPBC; BT-474) cells were used to examine such role. We show that TNBC cells had naturally less fat content than TPBC cells. Subsequently, the fat content increased in both cells when treated with Palmitate rather than Oleate, whereas both fatty acids produced apoptotic ultra-structural effects and attenuated FASN expression. However, Oleate increased FASN expression in TPBC cells. CDDP decreased FASN expression and increased apoptosis in TNBC cells. These effects were further enhanced by combining CDDP with fatty acids. We also illustrate that the inhibition of FASN by either siRNA or exogenous inhibitor decreased CDDP-induced apoptosis in TPBC cells suggesting its role as an apoptotic factor, while an opposite finding was observed in TNBC cells when siRNA and fatty acids were used, suggesting its role as a survival factor. To our knowledge, we are the first to demonstrate a dual role of FASN in CDDP-induced apoptosis in breast cancer cells and how it can modulate their chemosensitivity.

Original languageEnglish
Pages (from-to)865-876
Number of pages12
JournalApoptosis
Volume22
Issue number6
DOIs
Publication statusPublished - Jun 1 2017

Fingerprint

Fatty Acid Synthases
Cisplatin
Cells
Apoptosis
Breast Neoplasms
Fatty Acids
Fats
Oleic Acid
Small Interfering RNA
Palmitates
Biosynthesis
Cytotoxicity
Platinum
Triple Negative Breast Neoplasms
Pharmaceutical Preparations
Enzymes
Cell Line

Keywords

  • Apoptosis
  • Breast cancer
  • Fatty acid synthase
  • Oleate
  • Palmitate

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science
  • Clinical Biochemistry
  • Cell Biology
  • Biochemistry, medical
  • Cancer Research

Cite this

Fatty acid synthase regulates the chemosensitivity of breast cancer cells to cisplatin-induced apoptosis. / Al-Bahlani, Shadia; Al-Lawati, Hanaa; Al-Adawi, Moza; Al-Abri, Nadia; Al-Dhahli, Buthaina; Al-Adawi, Kawther.

In: Apoptosis, Vol. 22, No. 6, 01.06.2017, p. 865-876.

Research output: Contribution to journalArticle

Al-Bahlani, Shadia ; Al-Lawati, Hanaa ; Al-Adawi, Moza ; Al-Abri, Nadia ; Al-Dhahli, Buthaina ; Al-Adawi, Kawther. / Fatty acid synthase regulates the chemosensitivity of breast cancer cells to cisplatin-induced apoptosis. In: Apoptosis. 2017 ; Vol. 22, No. 6. pp. 865-876.
@article{60a1d003b5a74bc692af9a24d707fb39,
title = "Fatty acid synthase regulates the chemosensitivity of breast cancer cells to cisplatin-induced apoptosis",
abstract = "Fatty acid synthase (FASN) is a key enzyme in fat biosynthesis that is over-expressed in advanced breast cancer stages. Cisplatin (CDDP) is a platinum-based drug used in the treatment of certain types of this disease. Although it was shown that FASN inhibition induced apoptosis by enhancing the cytotoxicity of certain drugs in breast cancer, its role in regulating the chemosensitivity of different types of breast cancer cells to CDDP-induced apoptosis is not established yet. Therefore, two different breast cancer cell lines; triple negative breast cancer (TNBC; MDA-MB-231) and triple positive breast cancer (TPBC; BT-474) cells were used to examine such role. We show that TNBC cells had naturally less fat content than TPBC cells. Subsequently, the fat content increased in both cells when treated with Palmitate rather than Oleate, whereas both fatty acids produced apoptotic ultra-structural effects and attenuated FASN expression. However, Oleate increased FASN expression in TPBC cells. CDDP decreased FASN expression and increased apoptosis in TNBC cells. These effects were further enhanced by combining CDDP with fatty acids. We also illustrate that the inhibition of FASN by either siRNA or exogenous inhibitor decreased CDDP-induced apoptosis in TPBC cells suggesting its role as an apoptotic factor, while an opposite finding was observed in TNBC cells when siRNA and fatty acids were used, suggesting its role as a survival factor. To our knowledge, we are the first to demonstrate a dual role of FASN in CDDP-induced apoptosis in breast cancer cells and how it can modulate their chemosensitivity.",
keywords = "Apoptosis, Breast cancer, Fatty acid synthase, Oleate, Palmitate",
author = "Shadia Al-Bahlani and Hanaa Al-Lawati and Moza Al-Adawi and Nadia Al-Abri and Buthaina Al-Dhahli and Kawther Al-Adawi",
year = "2017",
month = "6",
day = "1",
doi = "10.1007/s10495-017-1366-2",
language = "English",
volume = "22",
pages = "865--876",
journal = "Apoptosis : an international journal on programmed cell death",
issn = "1360-8185",
publisher = "Springer Netherlands",
number = "6",

}

TY - JOUR

T1 - Fatty acid synthase regulates the chemosensitivity of breast cancer cells to cisplatin-induced apoptosis

AU - Al-Bahlani, Shadia

AU - Al-Lawati, Hanaa

AU - Al-Adawi, Moza

AU - Al-Abri, Nadia

AU - Al-Dhahli, Buthaina

AU - Al-Adawi, Kawther

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Fatty acid synthase (FASN) is a key enzyme in fat biosynthesis that is over-expressed in advanced breast cancer stages. Cisplatin (CDDP) is a platinum-based drug used in the treatment of certain types of this disease. Although it was shown that FASN inhibition induced apoptosis by enhancing the cytotoxicity of certain drugs in breast cancer, its role in regulating the chemosensitivity of different types of breast cancer cells to CDDP-induced apoptosis is not established yet. Therefore, two different breast cancer cell lines; triple negative breast cancer (TNBC; MDA-MB-231) and triple positive breast cancer (TPBC; BT-474) cells were used to examine such role. We show that TNBC cells had naturally less fat content than TPBC cells. Subsequently, the fat content increased in both cells when treated with Palmitate rather than Oleate, whereas both fatty acids produced apoptotic ultra-structural effects and attenuated FASN expression. However, Oleate increased FASN expression in TPBC cells. CDDP decreased FASN expression and increased apoptosis in TNBC cells. These effects were further enhanced by combining CDDP with fatty acids. We also illustrate that the inhibition of FASN by either siRNA or exogenous inhibitor decreased CDDP-induced apoptosis in TPBC cells suggesting its role as an apoptotic factor, while an opposite finding was observed in TNBC cells when siRNA and fatty acids were used, suggesting its role as a survival factor. To our knowledge, we are the first to demonstrate a dual role of FASN in CDDP-induced apoptosis in breast cancer cells and how it can modulate their chemosensitivity.

AB - Fatty acid synthase (FASN) is a key enzyme in fat biosynthesis that is over-expressed in advanced breast cancer stages. Cisplatin (CDDP) is a platinum-based drug used in the treatment of certain types of this disease. Although it was shown that FASN inhibition induced apoptosis by enhancing the cytotoxicity of certain drugs in breast cancer, its role in regulating the chemosensitivity of different types of breast cancer cells to CDDP-induced apoptosis is not established yet. Therefore, two different breast cancer cell lines; triple negative breast cancer (TNBC; MDA-MB-231) and triple positive breast cancer (TPBC; BT-474) cells were used to examine such role. We show that TNBC cells had naturally less fat content than TPBC cells. Subsequently, the fat content increased in both cells when treated with Palmitate rather than Oleate, whereas both fatty acids produced apoptotic ultra-structural effects and attenuated FASN expression. However, Oleate increased FASN expression in TPBC cells. CDDP decreased FASN expression and increased apoptosis in TNBC cells. These effects were further enhanced by combining CDDP with fatty acids. We also illustrate that the inhibition of FASN by either siRNA or exogenous inhibitor decreased CDDP-induced apoptosis in TPBC cells suggesting its role as an apoptotic factor, while an opposite finding was observed in TNBC cells when siRNA and fatty acids were used, suggesting its role as a survival factor. To our knowledge, we are the first to demonstrate a dual role of FASN in CDDP-induced apoptosis in breast cancer cells and how it can modulate their chemosensitivity.

KW - Apoptosis

KW - Breast cancer

KW - Fatty acid synthase

KW - Oleate

KW - Palmitate

UR - http://www.scopus.com/inward/record.url?scp=85017173843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017173843&partnerID=8YFLogxK

U2 - 10.1007/s10495-017-1366-2

DO - 10.1007/s10495-017-1366-2

M3 - Article

VL - 22

SP - 865

EP - 876

JO - Apoptosis : an international journal on programmed cell death

JF - Apoptosis : an international journal on programmed cell death

SN - 1360-8185

IS - 6

ER -